首页> 美国卫生研究院文献>Acta Pharmacologica Sinica >Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

【2h】

Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

机译：索拉非尼延长了肝移植后多发性肝细胞癌患者的生存时间

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim:To determine the efficacy and toxicities of sorafenib in the treatment of patients with multiple recurrences of hepatocellular carcinoma (HCC) after liver transplantation in a Chinese population.

机译：目的：确定索拉非尼在中国人群肝移植术后多发性肝细胞癌（HCC）患者中的疗效和毒性。

著录项

期刊名称 Acta Pharmacologica Sinica
作者
Wei-feng Tan; Zhi-quan Qiu; Yong Yu; Rong-zheng Ran; Bing Yi; Wan-yee Lau; Chen Liu; Ying-he Qiu; Fei-ling Feng; Jing-han Wang; Pei-ning Yan; Bai-he Zhang; Meng-chao Wu; Xiang-ji Luo; Xiao-qing Jiang;
展开▼
作者单位

展开▼
年(卷),期 2010(31),12
年度 2010
页码 1643–1648
总页数 6
原文格式 PDF
正文语种
中图分类药学;
关键词
hepatocellular carcinoma sorafenib transarterial chemoembolization survival analysis molecular targeted therapy;

机译：肝细胞癌;索拉非尼;经动脉化学栓塞;生存分析;分子靶向治疗;

相似文献

外文文献
中文文献
专利

1. Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation [J] . Wei-feng TAN, Jing-han WANG, Pei-ning YAN, 中国药理学报：英文版 . 2010,第012期

机译：索拉非尼延长了肝移植后多发性肝细胞癌患者的生存时间
2. Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation [J] . Wei-feng TAN, Zhi-quan QIU, Yong YU, 中国药理学报：英文版 . 2010,第012期

机译：索拉非尼延长了肝移植后多发性肝细胞癌患者的生存时间
3. Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era. [J] . Pfiffer TE, Seehofer D, Nicolaou A, Tumori. . 2011,第4期

机译：肝移植受者中复发性肝细胞癌：影响索拉非尼时代复发时间，治疗选择和生存的参数。
4. Magnetically Targeted Delivery of Sorafenib Through Magnetic Solid Lipid Nanoparticles Towards Treatment of Hepatocellular Carcinoma [C] . F. Vischio, N. Depalo, R. M. Iacobazzi, NATO Advanced Study Institute on Detection, Diagnosis and Health Concerns of Toxic Chemical and Biological Agents . 2020

机译：通过磁性固体脂质纳米粒子致磁性固体脂质纳米粒子对肝细胞癌治疗的磁性靶向递送
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation [O] . Yong-Kyu Chung, Shin Hwang, Gi-Won Song, 2018

机译：二甲双胍对索拉非尼治疗的肝切除和肝移植术后肝癌复发患者无抗肿瘤作用
7. Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation [O] . Wei-feng Tan, Zhi-quan Qiu, Yong Yu, 2010

机译：索拉非尼延长肝移植后肝细胞癌多次复发的患者的存活时间

Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

摘要

著录项

相似文献

相关主题

期刊订阅